Novavax CEO On Delayed U.S. Covid-19 Vaccine Trial

First on CNBC: CNBC Transcript: Novavax President & CEO Stanley Erck Speaks with CNBC’s “Squawk Box” today, discussing the delayed U.S. Covid-19 vaccine trial.Q3 2020 hedge fund letters, conferences and moreNovavax CEO On Delayed U.S. Covid-19 Vaccine TrialAll references must be sourced to CNBC.MEG TIRRELL: Melissa thanks so much. And Stan Erck, thanks for being with us this morning. You guys just put out an update on your plans for your late stage trials of your COVID vaccine, you’ve fully enrolled a Phase 3 in the UK and you’re expecting data early next year, fully enrolled a Phase 2B in Sou…

Read More

HEDGE accordingly